# A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B

> **NCT01327547** · PHASE4 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 138 (actual)

## Conditions studied

- HIV Coinfection

## Interventions

- **DRUG:** Maraviroc
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01327547
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05-18
- **Primary completion:** 2013-04-23
- **Final completion:** 2015-03-24
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2017-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01327547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01327547, "A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01327547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*